Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer97
Cost analyses for malaria molecular diagnosis for research planners in India and beyond60
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects55
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment53
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features47
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer36
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence36
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination33
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA33
What makes a « good » companion diagnostic in thoracic oncology?32
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology31
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome30
Evaluating emerging molecular diagnostics for severe infections in neutropenic patients with hematological malignancies28
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma28
The MALAT1-breast cancer interplay: insights and implications26
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma25
Diagnosing thrombophilia: the case for genetic or functional testing?25
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis24
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma23
CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer23
How mitochondrial DNA complicates pre-implantation genetic screening and management22
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study22
0.18702697753906